Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 269

    1.

    Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

    DECODE Study Group, European Diabetes Epidemiology Group.

    Diabetes Care. 2003 Mar;26(3):688-96.PMID: 12610023 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

    Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE.

    Diabetologia. 2009 Mar;52(3):415-24. Epub 2009 Jan 8.PMID: 19130039 [PubMed - indexed for MEDLINE]Related articles

    4.

    Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.

    Nakagami T; DECODA Study Group.

    Diabetologia. 2004 Mar;47(3):385-94. Epub 2004 Feb 18.PMID: 14985967 [PubMed - indexed for MEDLINE]Related articles

    5.

    Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.

    Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study.

    Diabetes Care. 2002 Oct;25(10):1845-50.PMID: 12351489 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study.

    Zhang L, Qiao Q, Tuomilehto J, Hammar N, Ruotolo G, Stehouwer CD, Heine RJ, Eliasson M, Zethelius B; DECODE Study Group.

    Atherosclerosis. 2009 Sep;206(1):298-302. Epub 2009 Feb 23.PMID: 19303072 [PubMed - in process]Related articles

    7.

    The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.

    Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R; Baltimore Longitudinal Study of Aging.

    Diabetes. 2003 Jun;52(6):1475-84.PMID: 12765960 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80.

    Kadowaki S, Okamura T, Hozawa A, Kadowaki T, Kadota A, Murakami Y, Nakamura K, Saitoh S, Nakamura Y, Hayakawa T, Kita Y, Okayama A, Ueshima H; NIPPON DATA Research Group.

    Diabetologia. 2008 Apr;51(4):575-82. Epub 2008 Jan 16.PMID: 18197396 [PubMed - indexed for MEDLINE]Related articles

    9.

    Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c.

    Qiao Q, Dekker JM, de Vegt F, Nijpels G, Nissinen A, Stehouwer CD, Bouter LM, Heine RJ, Tuomilehto J.

    J Clin Epidemiol. 2004 Jun;57(6):590-6.PMID: 15246127 [PubMed - indexed for MEDLINE]Related articles

    10.

    Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.

    Tai ES, Lim SC, Tan BY, Chew SK, Heng D, Tan CE.

    Diabet Med. 2000 Nov;17(11):771-5.PMID: 11131101 [PubMed - indexed for MEDLINE]Related articles

    12.

    Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese.

    Ko GT, Chan JC, Lau E, Woo J, Cockram CS.

    Diabetes Care. 1997 Feb;20(2):170-2.PMID: 9118766 [PubMed - indexed for MEDLINE]Related articles

    14.

    Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.

    Mula-Abed WA, Al-Naemi AH.

    Saudi Med J. 2003 May;24(5):477-84.PMID: 12847621 [PubMed - indexed for MEDLINE]Related articles

    15.

    Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study.

    Balkau B, Forhan A, Eschwège E.

    Diabetologia. 2002 Sep;45(9):1224-30. Epub 2002 Jul 6.PMID: 12242454 [PubMed - indexed for MEDLINE]Related articles

    16.

    From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000.

    Eschwège E, Charles MA, Simon D, Thibult N, Balkau B.

    Diabetes Care. 2001 Nov;24(11):1945-50.PMID: 11679462 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

    Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC.

    Diabetes Care. 1996 Sep;19(9):972-8.PMID: 8875091 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia.

    Tapp RJ, Zimmet PZ, Harper CA, de Courten MP, McCarty DJ, Balkau B, Taylor HR, Welborn TA, Shaw JE; AusDiab Study Group.

    Diabetes Res Clin Pract. 2006 Sep;73(3):315-21. Epub 2006 Apr 27.PMID: 16644057 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.

    Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC.

    Diabetes Care. 2000 Aug;23(8):1113-8.PMID: 10937507 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan.

    Wen CP, Cheng TY, Tsai SP, Hsu HL, Wang SL.

    Diabetes Care. 2005 Nov;28(11):2756-61.PMID: 16249552 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data